WO2006096951A2 - Isolated nucleic acid molecules encoding plant transcription factors in the hd-zip family - Google Patents

Isolated nucleic acid molecules encoding plant transcription factors in the hd-zip family Download PDF

Info

Publication number
WO2006096951A2
WO2006096951A2 PCT/BR2006/000050 BR2006000050W WO2006096951A2 WO 2006096951 A2 WO2006096951 A2 WO 2006096951A2 BR 2006000050 W BR2006000050 W BR 2006000050W WO 2006096951 A2 WO2006096951 A2 WO 2006096951A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
plant
seq
acid molecule
xylem
Prior art date
Application number
PCT/BR2006/000050
Other languages
French (fr)
Other versions
WO2006096951A3 (en
Inventor
Fabio Papes
Isabel Rodrigues Gerhardt
Paulo Arruda
Original Assignee
Alellyx S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alellyx S.A. filed Critical Alellyx S.A.
Priority to BRPI0608683-7A priority Critical patent/BRPI0608683B1/en
Publication of WO2006096951A2 publication Critical patent/WO2006096951A2/en
Publication of WO2006096951A3 publication Critical patent/WO2006096951A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine

Definitions

  • This invention relates to genetic engineering as applied to plants. More specifically, it relates to the isolation of nucleic acid molecules which are transcription factors and which are useful in producing genetically engineered, recombinant plants.
  • the resulting recombinant plants have an increased number of cells in the secondary xylem of the stem and root.
  • the resulting plants also exhibit altered xylem chemical composition, relative to non- recombinant plants.
  • Also a part of the invention are processes for making the recombinant plants.
  • Forestry represents an important global economic activity, generating products ranging from timber for the civil engineering business to cellulose for papermaking.
  • the nucleic acid molecules described herein code for plant transcription factors which, when over-expressed in plant species, result in increased xylem size and consequently in an improvement in wood formation and forest productivity.
  • the "HD" family of transcription factors is characterized by a conserved domain of 30-60 amino acids, referred to as a "homeodomain” (also known as “homeobox domain”). Many of the proteins in this family are recognized as sequence-specific DNA-binding transcription factors.
  • the present invention involves the isolation and cloning of nucleic acid molecules which serve as transcription factors belonging to this family.
  • the group of nucleic acid molecules and proteins of the invention will be referred to as the "WOOD-BOOSTER” molecules. Genetic alteration of plants via these nucleic acid molecules results in transgenic plants that differ from their non-transgenic counterparts in terms of altered xylem size and structure and/or chemical composition.
  • Figure 1 shows the domain organization of the polypeptides of the invention.
  • Figure 2 shows a generic plant expression vector which delineates the various parts of the vector. Variations are described in the specification.
  • Figures 3A, 3B and 3C present results obtained following genetic transformation and growth of Nicotiana benthamiana using expression vectors in accordance with the invention.
  • Hand-cut traverse stem sections are shown in the panels, visualized under a stereomicroscope ( Figure 3A and 3B) or under a light transmission microscope ( Figure 3C).
  • the transformants in each panel are on the right, while non-transformed control plants are on the left. Note the increased width of the secondary xylem in the transgenic plants as compared to the non- transgenic controls.
  • FIG. 4 shows microtome histological sections of plants in the segregating Tl population. These plants were obtained from seeds collected from a primary transformant (event number 50) containing a construct comprising the "WOOD-BOOSTER" nucleic acid from Populus deltoides under the control of a xylem-preferred alpha-tubulin promoter. Note the cell aggregates in discrete regions of the cambial zone in AA and A0 plants (arrowheads) as compared with control sibling 00 plants from the same segregating progeny. DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • PCR-primer pairs can be derived from known sequences by known techniques such as using computer programs intended for that purpose (e.g., Primer, Version 0.5 (1991), Whitehead Institute for Biomedical Research, Cambridge, MA). Methods for chemical synthesis of nucleic acids are discussed, for example, in Beaucage and Caruthers, Tetra. Letts., 22:1859-1862 (1981) and Matteucci and Caruthers, J. Am. Chem. Soc, 103:3185 (1981).
  • ESTs Expressed Sequence Tags (ESTs) from Populus sp. were clustered using the CAP3 program (Huang and Madan, Genome Res., 9:868-877 (1999)), incorporated by reference.
  • the 150,000 ESTs were obtained from libraries representing the following tissues: apical shoot, bark, cambium, seed, xylem, leaf and root.
  • the set of clusters thus generated was searched for clusters composed of at least 90% of EST reads from libraries representing Popidns cambium and xylem tissues. Additionally, the set of clusters was searched for clusters composed of at least three EST reads from cambium and xylem tissues and preferably less than two reads from other libraries.
  • AGRIS Gene Regulator Information Server
  • Bark was removed from stem cuttings of one-year-old Populus deltoides frees.
  • CCTAB cetyltrimethyl-ammonium bromide
  • a cDNA pool was used in RT-PCR experiments in which the isolated total RNA was used as template, and Superscript II reverse transcriptase (Invitrogen) and oligo(dT) primer were used to synthesize the first-strand cDNA. Double-stranded cDNA was obtained by the subsequent polymerase reaction, using gene-specific primers, as described below.
  • Oligomers based on SEQ. ID. NO: 1 were synthesized as primers for PCR, including either the region around the first ATG codon or around the termination codon of the main ORF encoding the polypeptide to amplify the entire coding region of the main ORF.
  • the sequences of the primers are: SEQ. ID. NO: 5
  • the cDNA pool obtained in (a) was used as the template in a PCR reaction with the primers of SEQ. ID. NOs: 5 and 6.
  • the PCR involved 40 cycles of 1 minute at 94°C, 1 minute at 51 0 C, and 2 minutes at 72°C followed by an extra step of elongation at 72°C for 7 minutes.
  • the PCR products were isolated by gel electrophoresis on 1.0% agarose followed by ethidium bromide staining of the electrophoresed gel and detection of amplified bands on a UV transilluminator. The detected amplified band was verified and cut out of the agarose gel with a razor.
  • the pieces of gel were transferred to 1.5mL microtubes, and the DNA fragments were isolated and purified using a GFX PCR clean-up and gel band purification kit (Amersham).
  • the recovered DNA fragments were subcloned in a commercially available cloning vector, transformed into E. coli, and then used to prepare plasmid DNA, which was then sequenced by the dideoxy method (Messing, Methods in Enzymol. 101, 20-78 (1983)) using standard methods.
  • the nucleotide sequence SEQ. ID. NO: 2 which codes for the polypeptide disclosed herein under SEQ. ID. NO: 4, resulted.
  • nucleic acid molecule from Populus deltoides obtained in Example 2 above was introduced into a plant host to produce transgenic tobacco plants.
  • the nucleic acid molecule isolated from Populus deltoides and obtained in Example 2 was cloned into an expression vector (Figure 2) downstream of a xylem-preferred alpha-rubulin gene (TUB) promoter disclosed in international patent application PCT/BR2005/000041, filed March 28, 2005, which is incorporated here by reference.
  • the resulting expression construct was amplified in E. coli, and then transformed by chemical transformation into Agrobacterium tumefaciens LBA4404 strain.
  • Agrobacterium-mediated transformation of Nicoti ⁇ n ⁇ benth ⁇ mi ⁇ n ⁇ or Nicoti ⁇ n ⁇ t ⁇ b ⁇ cum was accomplished using the leaf disk method of Horsch et al. (Science 227, 1229, (1985)). In short, LBA4404 Agrobacterium strain was grown overnight until it reached mid-log phase growth. The cultures were diluted 1:10 in sterile water and co-cultivated for 20 min with leaf disks from sterile grown young Nicotiana plants. These disks were incubated on Murashige- Skoog medium in the dark.
  • leaf disks were placed upside down on fresh plates of the same growth medium supplemented with 0.4 mg/L of indoleacetic acid (IAA), 2 mg/L benzyl-aminopurine (hOBAP), lmg/L Finale and 500 mg/L carbenicillin.
  • IAA indoleacetic acid
  • hOBAP benzyl-aminopurine
  • lmg/L Finale 500 mg/L carbenicillin.
  • shoots formed they were removed from the leaf disk and placed on fresh medium supplemented with just 1 mg/L Finale.
  • Shoots of primary transformants of Nicotiana heterozygous for the transgene, were allowed to root on Murashige and Skoog medium, and subsequently transferred to soil and grown in the greenhouse.
  • PCR was used to verify the integration of the gene construct in the genome of the transgenic plants.
  • a pair of primers was synthesized to amplify a 400bp DNA sequence from the selectable marker gene Bar. Additionally, another pair was synthesized to amplify the endogenous Nicotiana chalcone synthase (CHS) gene:
  • Bar 36 Length: 23 AATTCGGGGGATCTGGATTTTAG (SEQ ID NO: 8)
  • CHS 150 Length: 2 GCCAGCCCAAATCCAAGATTACTC (SEQ ID NO: 9)
  • the bar primers were used to PCR-amplify part of the T-DNA portion of the expression construct containing a nucleic acid molecule of the invention, i.e., from genomic DNA of Nicotiana transformants.
  • the PCR reaction mixture contained 100 ng genomic DNA of transformed plant, prepared using the cetyltrimethyl-ammonium bromide (CTAB) extraction method (Aldrich and Cullis, Plant MoI. Biol. Report., 11 :128-141 (1993)), 0.2 ⁇ M of each primer for the Bar gene, 0.2 ⁇ M of each primer for the endogenous CHS control gene, 100 ⁇ M of each deoxyribonucleotide triphosphate, IxPCR buffer and 2.5 Units of AmpliTaq DNA polymerase (Applied Biosystems) in a total volume of 50 ⁇ L.
  • the cycling parameters were as follows: 94°C. for 1 minute, 57°C. for 1 minute and 72°C for 1 minute, for 40 cycles, with 5 minutes at 72°C. extension.
  • the PCR products were electrophoresed on a 1 % agarose gel.
  • transcription factors which are members of the "homeodomain-containing”, or “HD”, family of transcription factors. Members of this family share a conserved DNA-binding domain of 30-60 amino acids, which was first identified in Drosophila homeotic and segmentation proteins, and which binds to DNA through a "helix turn helix” structure.
  • HD transcription factors are divided into three groups, of which the homeodomain-leucine zipper, abbreviated as "HD-zip", is relevant here.
  • the members of this family share a common structural organization, consisting of three main regions. These include conserved b-ZIP and START domains, as well as the HD domain referred to supra ( Figure 1).
  • proteins are further divided into three classes, of which class III contains the proteins relevant to this patent. Proteins in the HD-zip family have a variety of developmental functions in plants and animals (Johanesson, H., Functional analysis of homeodomain-leucine zipper transcription factors in Arabidopsis thaliana, thesis dissertation, Uppsala University, Sweden), but class III HD-zip proteins seem to be plant-specific factors.
  • nucleic acid molecules and proteins of the invention are their preferred expression pattern in secondary xylem and cambium tissues of plants.
  • the isolated nucleic acid molecules of the invention are represented by, but are not limited to, those defined as comprising the nucleotide sequence of SEQ. ID. NO: 1 or 2, as well as those which exhibit 65% or more homology therewith, as is discussed infra.
  • the isolated nucleic acid molecules of the invention are capable of hybridizing, under stringent conditions, to one or both of SEQ. ID. NOS: 1 and 2.
  • Stringent conditions refers to conditions at least as stringent as those where hybridization is carried out in 3.5x SSC, Ix Denhardt's solution, 25mM sodium phosphate buffer (pH 7.0), 0.5% SDS, and 2mM EDTA for 18 hours, at 65°C, followed by four washes at 65 0 C for 20 minutes per wash, in 2x SSC, 0.1% SDS, and a final wash for up to 20 minutes, in 0.5x SSC, 0.1% SDS, or lower concentrations of SSC, e.g., 0.3x SSC, 0.1% SDS or O.lx SSC, 0.1% SDS, for even greater stringency.
  • nucleic acid molecules which encode the same protein as the nucleic acid molecules described supra, but differ in nucleotide sequence as a result of degeneracy of the genetic code, as well as those nucleic acid molecules which encode proteins that have at least about 60%, preferably at least about 70%, more preferably at least about 80% and most preferably at least 90% of the activity of SEQ. ID. NOS: 3 and 4.
  • nucleic acid molecules of the invention include, e.g., allelic variants. These are nucleic acid molecules which vary in nucleotide sequence from the reference sequences supra, and lead to changes in amino acid translation, but are subject to no more than about 5% variation in the nucleotide sequence.
  • the nucleic acid molecules of the invention contain regions which encode a conserved START domain.
  • SEQ. ID. NOS: 3 and 4 present START domains at amino acids 165-375.
  • the invention encompasses those nucleic acid molecules which encode proteins that include amino acid sequences that are at least 80%, more preferably 85%, even more preferably at least 90% and most preferably at least 95% identical to the START domain described supra, and which have at least 60% of the biological activity of the proteins encoded by SEQ. ID. NO: 1 or 2.
  • Bio activity refers to the properties described in the examples, supra.
  • the isolated nucleic acid molecules of the invention may be incorporated into expression vectors, such that they are in operable linkage with a promoter.
  • the promoter is one known to operate in plant cells, and more preferably to be operable in cells of specific plant organs or tissues, such as roots, shoots, leaves, xylem, etc.
  • the nucleic acid molecules of the invention may be placed in operable linkage with constitutive or inducible promoters.
  • the nucleic acid molecules of the invention may be placed in operable linkage with promoters which direct the expression of the downstream gene preferably or specifically to an organ or tissue of the plant, such as xylem and cambium.
  • the expression vectors of the invention may also contain termination sequences, which are positioned downstream of the nucleic acid molecules of the invention, such that transcription of mRNA is terminated, and polyA sequences added.
  • termination sequences are the cauliflower mosaic virus (CaMV) 35S terminator and the nopaline synthase gene (Tnos) terminator.
  • the expression vectors of the invention may include a developmentally regulated promoter, an organelle specific promoter, a seed specific promoter, a plastid specific promoter, and so forth. Coding sequences for targeting, transit, or secretion protein encoding molecules may also be included. Enhancers, transcription terminators, start codons, splicing signal sequences, and so forth, may also be included. For example, if a transcription initiation region is included, it may be, e.g., any of the various opine initiation regions, such as octopine, mannopine, nopaline and the like that are found in the Ti plasmids of Agrobacteriiim tumefaciens.
  • plant viral promoters can also be used, such as the cauliflower mosaic virus 35S promoter, to control gene expression in a plant.
  • plant promoters such as leaf-specific promoters, root-specific promoters, seed-specific promoters, etc. can also be used.
  • the most preferred promoters are tissue-preferred promoters which are active in, e.g., the cambium and/or xylem, particularly xylem fiber cells.
  • promoter includes a sequence sufficient to direct transcription, such as promoter elements which are sufficient to render promoter-dependent gene expression controllable for cell-type specific, tissue-specific, environmentally- or developmentally-regulated, or expression that is inducible by external signals or agents. Such elements may be located in the 5' and/or 3' regions of the construct. Both constitutive and inducible promoters are included (see e.g., Bitter et al., Methods in Enzymol., 153:516-544 (1987), incorporated by reference).
  • genes employed in the present invention may be driven by more than one promoter in different circumstances.
  • the endogenous promoter of a structural gene of interest for example that of a gene of the present invention, may be utilized for transcriptional regulation of the gene, the promoter may also be a foreign regulatory sequence.
  • suitable viral promoters include the 35S RNA and 19S RNA promoters of CaMV (Brisson et al., Nature, 310:51-61 (1984); Odell et al., Nature, 313:810 (1985)); the enhanced CaMV 35S promoter; the Figwort Mosaic Virus (FMV) promoter (Gowda et al., J.
  • tissue specific promoters may also be utilized in the present invention.
  • tissue-specific promoter means a DNA sequence that serves as a promoter, i.e., regulates expression of a selected DNA sequence operably linked to the promoter, effecting expression of said selected DNA sequence in specific cells, e.g., in the root or in the shoot of a plant.
  • the term also covers the so-called “leaky” promoters, which regulate expression of a selected DNA primarily in one tissue, but may cause minor expression in other tissues as well.
  • Such promoters may also include additional DNA sequences that are necessary for expression, such as introns and enhancer sequences.
  • tissue-specific promoters active in floral meristems are the promoters of the Apetala3 and Apetalal genes which are described in Jack et al., Cell, 76:703 (1994) and Hempel et al., Development, 124:3845 (1997).
  • vascular system-specific, xylem-specific or xylem preferred promoters may be useful to promote expression of the nucleic acid molecules of the invention specifically in vascular tissues, especially xylem tissue.
  • a constitutive promoter in general, affects protein levels and functions in all parts of the plant, while use of a tissue-preferred promoter permits targeting of the modified gene expression to specific plant parts, leading to more controllable phenotypes.
  • tissue-preferred promoter permits targeting of the modified gene expression to specific plant parts, leading to more controllable phenotypes.
  • Vascular tissue-specific, xylem-specific, vascular tissue-preferred and xylem-preferred promoters that could be used include, but are not limited to, the xylem-preferred tubulin (TUB) gene promoter, the xylem-preferred lipid transfer protein (LTP) gene promoter and the xylem-preferred coumarate-4-hydroxylase (C4H) gene promoter.
  • TTB tubulin
  • LTP xylem-preferred lipid transfer protein
  • C4H coumarate-4-hydroxylase
  • the particular promoter selected should be capable of causing sufficient expression to result in the over-expression of the protein of the invention to modify the size of the xylem or to modify the chemical composition of the xylem of a plant or yet a combination of these effects.
  • a constitutive promoter such as the CaMV promoter discussed supra
  • a tissue-specific promoter preferably a xylem preferred promoter as described supra
  • the promoter may be operably linked to the nucleic acid coding region in any manner known to one of skill in the art.
  • the expression unit may be further optimized by employing supplemental elements such as transcription terminators and/or enhancer elements.
  • Transcription terminators or termination regions downstream of the structural gene provide for efficient transcription termination.
  • the termination region may be obtained from the same gene as the promoter sequence or may be obtained from a different gene. If the mRNA encoded by the structural gene is to be efficiently processed, DNA sequences which direct polyadenylation sequences, including, but not being limited to, the Agrobacterium octopine synthase signal (Gielen et al., EMBO J., 3:835-846 (1984)) or the nopaline synthase signal (Depicker et al., MoI. And Appl. Genet., 1:561-573 (1982)), are also used.
  • the expression vectors of the invention When inserted into plants or plant cells, the expression vectors of the invention will typically contain, in addition to the protein coding nucleotide sequence, a plant promoter region, a transcription initiation site and a transcription termination sequence. Unique restriction enzyme sites at the 5' and 3' ends of the expression unit may also be included to allow for easy insertion into a preexisting vector.
  • An additional embodiment of the invention is a recombinant expression vector comprising a promoter, said promoter being functional in a plant cell, and a nucleic acid molecule in accordance with the invention, operably linked to said promoter, wherein said nucleic acid molecule comprises a nucleotide sequence of at least 21 contiguous nucleotides from a sequence chosen from SEQ ID. NOS: 1 or 2, in antisense orientation. More preferably, the sequence contains 21 — 300 contiguous nucleotides from a sequence chosen from SEQ ID. NOS: 1 or 2, in antisense orientation.
  • Such constructs are useful for inhibiting and/or decreasing expression of the relevant genes.
  • the nucleotide sequence comprises a nucleic acid molecule selected from the group consisting of: (a) SEQ. ID. NOS: 1 or 2, or a part thereof, or a complement thereof; (b) a nucleotide sequence that hybridizes to said nucleotide sequence of (a) under a wash stringency equivalent to 0.1X SSC to l.OX SSC, 0.1 % SDS, at 50- 65 0 C, and which encodes a polypeptide having at least 60% of the activity of Populus deltoides polypeptide disclosed herein, (c) a nucleotide sequence encoding a protein having the same amino acid sequence as is encoded by the nucleotide sequence of (a), but which is degenerate in accordance with the degeneracy of the genetic code; and (d) a nucleotide sequence encoding the same amino acid sequence as said nucleotide sequence of (b), but which is degenerate in accordance with the degen
  • Another embodiment of the invention is a recombinant expression vector comprising a promoter functional in a plant cell, a nucleic acid molecule which is a homologue of the nucleotide sequences described supra, and which encodes a polypeptide whose amino acid sequence contains regions that are at least 80% identical to the START domain of SEQ ID. NOS: 3 and 4, as described supra, and which exhibits at least 60% of the biological activity of the polypeptides shown in SEQ ID. NOS: 3 or 4. More preferably, the nucleic acid molecule encodes a polypeptide whose amino acid sequence contains regions that are at least 85%, 90% or even 95% identical to the START sequence supra.
  • Expression vectors of the invention may also contain a selection marker by which transformed plant cells can be identified in culture.
  • the marker may be associated with the heterologous nucleic acid molecule, i.e., the gene operably linked to a promoter.
  • the term "marker” refers to a gene encoding a trait or a phenotype that permits the selection of, or the screening for, a plant or plant cell containing the marker.
  • the marker gene will encode antibiotic resistance. This allows for selection of transformed cells from among cells that are not transformed or transfected. Alternatively the marker gene may confer herbicide resistance.
  • Suitable selectable markers include adenosine deaminase, dihydrofolate reductase, hygromycin-B-phosphotransferase, thymidne kinase, xanthine-guanine phospho-ribosyltransferase, glyphosate and glufosinate resistance and amino-glycoside 3'-O- phosphotranserase (kanamycin, neomycin and G418 resistance). These markers include resistance to G418, hygromycin, bleomycin, kanamycin, and gentamicin.
  • the construct may also contain the selectable marker gene Bar that confers resistance to herbicidal phosphinothricin analogs like ammonium gluphosinate (Thompson et al, EMBO J. 9:2519-2523 (1987)).
  • selectable marker gene Bar confers resistance to herbicidal phosphinothricin analogs like ammonium gluphosinate (Thompson et al, EMBO J. 9:2519-2523 (1987)).
  • Other suitable selection markers are known to those of skill in the art.
  • Replication sequences may also be included to allow the vector to be cloned in a bacterial or phage host.
  • a broad host range prokaryotic origin of replication is used.
  • a selectable marker for bacteria may be included to allow selection of bacterial cells bearing the desired construct. Suitable prokaryotic selectable markers also include resistance to antibiotics such as kanamycin or tetracycline.
  • T-DNA sequences may be included to facilitate the subsequent transfer to and incorporation into plant chromosomes.
  • a further feature of the invention are proteins and polypeptides encoded by the nucleic acid molecules of the invention, exemplified by, but not being limited to, the polypeptides which have the amino acid sequences of SEQ ID. NOS: 3 and 4.
  • the polypeptides of the invention have amino acid sequences which contain regions that are at least 80% identical to the conserved START domain referred to supra. Identity greater than 80% is preferred, while identity greater than 85%, 90% or even 95% with respect to the START domain is preferred.
  • the polypeptide has at least 60% of the biological activity of a polypeptide from the group shown in SEQ ID. NOS: 3 or 4.
  • antibodies that are specific thereto can be generated, and these antibodies, which may be polyclonal, monoclonal, chimeric, or produced via recombinant means in some way, manner or form, are all covered by the invention as are the means of producing these, including, e.g.,. hybridomas, recombinant cells containing nucleic acid molecules that produce the antibodies, and the antibody-producing nucleic acid molecules themselves.
  • the presence of the proteins, polypeptides, and/or nucleic acid molecules in a particular cell can be measured to determine if, e.g., a cell has been successfully transformed or transfected.
  • the ability to carry out such assay is well known and need not be reiterated here.
  • nucleic acid molecules of the invention may be used "neat", or preferably in expression vector constructs, to transform or transfect cells, such as plant cells. Standard molecular biological- techniques, well known to the skilled artisan, may be used.
  • Both dicot and monocot cells may be so transformed or transfected.
  • Cells can be so treated before differentiating into plant organs, and can also be treated so as to transform or transfect particular plant organs, such as seeds, fruit, leaves, stems, wood, flowers and so forth.
  • Exemplary of such plants are those which have economic value such as, but not limited to, turf grasses, leafy plants such as tobacco, spinach, and lettuce, maize, wheat, rye, oat, triticale, rice, barley, soybean, peanut, cotton, rapeseed, canola, manioc, pepper, sunflower, marigold, solanaceous plants such as, potato, eggplant, tomato, Vicia species, pea, alfalfa, coffee, cacao, tea, Salix species, oil palm, coconut, perennial grass, forage crops, seed-bearing plant, such as rice, corn, soy and bean, and woody trees, such as poplar, eucalyptus, pine, spruce, fir, etc.
  • turf grasses leafy plants such as tobacco, spinach, and lettuce
  • maize wheat, rye, oat, triticale, rice, barley, soybean, peanut, cotton, rapeseed, canola, manioc, pepper, sunflower, marigold, solan
  • Agrobacterium may be transformed with a plant expression vector via, e.g., electroporation, after which the Agrobacterium is introduced to plant cells via, e.g., the well known leaf-disk method.
  • Additional methods for accomplishing this include, but are not limited to, electroporation, particle gun bombardment, calcium phosphate precipitation, and polyethylene glycol fusion, transfer into germinating pollen grains, direct transformation (Lorz, et al., MoI. Genet. 199: 179-182 (1985)), and other methods known to the art. If a selection marker, such as kanamycin resistance, is employed, it makes it easier to determine which cells have been successfully transformed.

Abstract

Polynucleotides, DNA constructs and methods are disclosed for the modification of the structure and/or chemical composition of the xylem of a plant. Plants are transformed with a gene encoding an active transcription factor belonging to the HD-zip family. The over- expression of this gene in the plant's vascular system leads to increased number of xylem cells in the transgenic plant.

Description

ISOLATED NUCLEIC ACID MOLECULES ENCODING PLANT TRANSCRIPTION FACTORS IN THE HD-ZIP FAMILY
FIELD OF THE INVENTION
[0001] This invention relates to genetic engineering as applied to plants. More specifically, it relates to the isolation of nucleic acid molecules which are transcription factors and which are useful in producing genetically engineered, recombinant plants. The resulting recombinant plants have an increased number of cells in the secondary xylem of the stem and root. The resulting plants also exhibit altered xylem chemical composition, relative to non- recombinant plants. Also a part of the invention are processes for making the recombinant plants.
BACKGROUND AND PRIOR ART
[0002] Forestry represents an important global economic activity, generating products ranging from timber for the civil engineering business to cellulose for papermaking.
[0003] Countries like China, India, Russia, The United States, Japan, Indonesia, Brazil and Thailand house large areas of planted forests adding up to about 500 million acres, of which a significant portion is used for the generation of products worth billions of dollars.
[0004] Extensive scientific efforts have been put in place over the past 50 years for the isolation of genetically improved trees; however, long generation times and narrow genetic bases have restricted progress in these areas, yielding only moderately improved plants, in terms of both productivity and quality.
[0005] As a result of recent advances in the understanding of basic molecular processes underlying wood formation and development, increasing importance has been given to the field of biotechnology as a way to rapidly and effectively improve tree crop species worldwide. The manipulation of gene expression in plants provides a general methodology for introducing new characteristics, such as increased wood size, which in turn leads to increased forest productivity.
[0006] The nucleic acid molecules described herein code for plant transcription factors which, when over-expressed in plant species, result in increased xylem size and consequently in an improvement in wood formation and forest productivity. [0007] The "HD" family of transcription factors is characterized by a conserved domain of 30-60 amino acids, referred to as a "homeodomain" (also known as "homeobox domain"). Many of the proteins in this family are recognized as sequence-specific DNA-binding transcription factors.
[0008] The present invention involves the isolation and cloning of nucleic acid molecules which serve as transcription factors belonging to this family. The group of nucleic acid molecules and proteins of the invention will be referred to as the "WOOD-BOOSTER" molecules. Genetic alteration of plants via these nucleic acid molecules results in transgenic plants that differ from their non-transgenic counterparts in terms of altered xylem size and structure and/or chemical composition.
[0009] How this is achieved will be seen from the disclosure which follows.
BRIEF DESCRIPTION OF THE FIGURES
[0010] Figure 1 shows the domain organization of the polypeptides of the invention.
[0011] Figure 2 shows a generic plant expression vector which delineates the various parts of the vector. Variations are described in the specification.
[0012] Figures 3A, 3B and 3C present results obtained following genetic transformation and growth of Nicotiana benthamiana using expression vectors in accordance with the invention. Hand-cut traverse stem sections are shown in the panels, visualized under a stereomicroscope (Figure 3A and 3B) or under a light transmission microscope (Figure 3C). The transformants in each panel are on the right, while non-transformed control plants are on the left. Note the increased width of the secondary xylem in the transgenic plants as compared to the non- transgenic controls.
[0013] Figure 4 shows microtome histological sections of plants in the segregating Tl population. These plants were obtained from seeds collected from a primary transformant (event number 50) containing a construct comprising the "WOOD-BOOSTER" nucleic acid from Populus deltoides under the control of a xylem-preferred alpha-tubulin promoter. Note the cell aggregates in discrete regions of the cambial zone in AA and A0 plants (arrowheads) as compared with control sibling 00 plants from the same segregating progeny. DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[0014] All technical terms used herein are terms commonly used in biochemistry, molecular biology and agriculture, and are readily understood by one of ordinary skill in the art. See, e.g., Molecular Cloning: A Laboratory Manual, 3ld ed., vol. 1-3, ed. Sambrook and Russel, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y., 2001; Current Protocols in Molecular Biology, ed. Ausubel et al., Greene Publishing Associates and Wiley-Interscience, New York (1988); Short Protocols in Molecular Biology: A compendium of Methods from Current Protocols in Molecular Biology, 5th ed., vol. 1-2, ed. Ausubel et al., John Wiley & Sons, Inc. (2002); Genome Analysis: A Laboratory Manual, vol. 1-2, ed. Green et al., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. (1997). Methods involving plant biology techniques are described herein and are described in detail in works such as Methods in Plant Molecular Biology: A Laboratory Course Manual, ed. Maliga et al., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y., 1995. Various techniques using PCR are described, e.g., in Innis et al., PCR Protocols: A Guide to Methods and Applications, Academic Press, San Diego, 1990 and in Dieffenbach and Dveksler, PCR Primer: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y., 2003. PCR-primer pairs can be derived from known sequences by known techniques such as using computer programs intended for that purpose (e.g., Primer, Version 0.5 (1991), Whitehead Institute for Biomedical Research, Cambridge, MA). Methods for chemical synthesis of nucleic acids are discussed, for example, in Beaucage and Caruthers, Tetra. Letts., 22:1859-1862 (1981) and Matteucci and Caruthers, J. Am. Chem. Soc, 103:3185 (1981).
[0015] Restriction enzyme digestions, phosphorylations, ligations and transformations were done as described in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press. AU reagents and materials used for the growth and maintenance of bacterial cells are widely available commercially.
EXAMPLE 1
[0016] Expressed Sequence Tags (ESTs) from Populus sp. were clustered using the CAP3 program (Huang and Madan, Genome Res., 9:868-877 (1999)), incorporated by reference. The 150,000 ESTs were obtained from libraries representing the following tissues: apical shoot, bark, cambium, seed, xylem, leaf and root. The set of clusters thus generated was searched for clusters composed of at least 90% of EST reads from libraries representing Popidns cambium and xylem tissues. Additionally, the set of clusters was searched for clusters composed of at least three EST reads from cambium and xylem tissues and preferably less than two reads from other libraries.
[0017] Clusters selected using these parameters were then aligned, using the Blast-X algorithm with a cutoff e-value <= le-5 (Altschul et al, Nucleic Acids Res., 25:3389-3402 (1997)), to sequences from a curated Arabidopsis thaliana transcription factor database composed of sequences obtained from the Arabidopsis Gene Regulator Information Server (AGRIS) AtTFDB database (http://arabidopsis.med.ohio-state.edu/AtTFDB/). (TAKE THIS OUT. THE PATENT OFFICE DOES NOT PERMIT BROWSER CODE)The comparison results were stored in a local database of Populiis transcription factors and browsed via a web- based interface to filter specific transcription factor cluster sequences of genes expressed specifically or preferably in the xylem and cambium tissues of Populus sp. Clusters coding for HD transcription factors were retrieved using this procedure as xylem/cambium-preferred HD transcription factors. One cluster thus selected, composed of 13 EST reads from xylem and cambium cDNA libraries and 4 reads from other libraries (leaf and apical shoot), represents an HD-zip transcription factor family member. The sequence of the longest read in this cluster is set forth herein as SEQ. ID. NO: 1, which codes for the polypeptide disclosed herein under SEQ. ID. NO: 3.
EXAMPLE 2
[0018] (a) Preparation of RNA from Populus deltoides cambium/xylem and cDNA synthesis.
[0019] Bark was removed from stem cuttings of one-year-old Populus deltoides frees. The inner part of the stem, containing cambium, xylem and pith, was cut in small pieces, frozen in liquid nitrogen and used for RNA extraction using the cetyltrimethyl-ammonium bromide (CTAB) extraction method (Aldrich and Cullis, Plant MoI. Biol. Report., 11 :128-141 (1993)). A cDNA pool was used in RT-PCR experiments in which the isolated total RNA was used as template, and Superscript II reverse transcriptase (Invitrogen) and oligo(dT) primer were used to synthesize the first-strand cDNA. Double-stranded cDNA was obtained by the subsequent polymerase reaction, using gene-specific primers, as described below. [0020] (b) Design of PCR Primers and RT-PCR reaction.
[0021] Oligomers based on SEQ. ID. NO: 1 were synthesized as primers for PCR, including either the region around the first ATG codon or around the termination codon of the main ORF encoding the polypeptide to amplify the entire coding region of the main ORF. The sequences of the primers are: SEQ. ID. NO: 5
ATCCATATGATGGCTGTAAGCTCGACGTG SEQ. ID. NO: 6 ATCGAGCTCGGCCAAAGTGTCACACAAAAGACC
[0022] The cDNA pool obtained in (a) was used as the template in a PCR reaction with the primers of SEQ. ID. NOs: 5 and 6. The PCR involved 40 cycles of 1 minute at 94°C, 1 minute at 510C, and 2 minutes at 72°C followed by an extra step of elongation at 72°C for 7 minutes. The PCR products were isolated by gel electrophoresis on 1.0% agarose followed by ethidium bromide staining of the electrophoresed gel and detection of amplified bands on a UV transilluminator. The detected amplified band was verified and cut out of the agarose gel with a razor. The pieces of gel were transferred to 1.5mL microtubes, and the DNA fragments were isolated and purified using a GFX PCR clean-up and gel band purification kit (Amersham). The recovered DNA fragments were subcloned in a commercially available cloning vector, transformed into E. coli, and then used to prepare plasmid DNA, which was then sequenced by the dideoxy method (Messing, Methods in Enzymol. 101, 20-78 (1983)) using standard methods. The nucleotide sequence SEQ. ID. NO: 2, which codes for the polypeptide disclosed herein under SEQ. ID. NO: 4, resulted.
EXAMPLE 3
[0023] The nucleic acid molecule from Populus deltoides obtained in Example 2 above was introduced into a plant host to produce transgenic tobacco plants.
The nucleic acid molecule isolated from Populus deltoides and obtained in Example 2 was cloned into an expression vector (Figure 2) downstream of a xylem-preferred alpha-rubulin gene (TUB) promoter disclosed in international patent application PCT/BR2005/000041, filed March 28, 2005, which is incorporated here by reference. The resulting expression construct was amplified in E. coli, and then transformed by chemical transformation into Agrobacterium tumefaciens LBA4404 strain.
[0024] Agrobacterium-mediated transformation of Nicotiαnα benthαmiαnα or Nicotiαnα tαbαcum was accomplished using the leaf disk method of Horsch et al. (Science 227, 1229, (1985)). In short, LBA4404 Agrobacterium strain was grown overnight until it reached mid-log phase growth. The cultures were diluted 1:10 in sterile water and co-cultivated for 20 min with leaf disks from sterile grown young Nicotiana plants. These disks were incubated on Murashige- Skoog medium in the dark. After 48 hours, leaf disks were placed upside down on fresh plates of the same growth medium supplemented with 0.4 mg/L of indoleacetic acid (IAA), 2 mg/L benzyl-aminopurine (hOBAP), lmg/L Finale and 500 mg/L carbenicillin. When shoots formed, they were removed from the leaf disk and placed on fresh medium supplemented with just 1 mg/L Finale. Shoots of primary transformants of Nicotiana, heterozygous for the transgene, were allowed to root on Murashige and Skoog medium, and subsequently transferred to soil and grown in the greenhouse. The conditions (~50 pM/m2/sec of while light, 27°C) were sufficient to identify those transgenic plants which exhibited altered xylem structure and/or xylem chemical composition, or a combination of these effects, according to the descriptions provided herein.
EXAMPLE 4
[0025] PCR was used to verify the integration of the gene construct in the genome of the transgenic plants. A pair of primers was synthesized to amplify a 400bp DNA sequence from the selectable marker gene Bar. Additionally, another pair was synthesized to amplify the endogenous Nicotiana chalcone synthase (CHS) gene:
Bar 35: Length: 20
TCTACCATGAGCCCAGAACG (SEQ ID NO: 7)
Bar 36: Length: 23 AATTCGGGGGATCTGGATTTTAG (SEQ ID NO: 8)
CHS 150: Length: 2 GCCAGCCCAAATCCAAGATTACTC (SEQ ID NO: 9) CHS 151: Length: 23
AATGTTAGCCCAACTTCACGGAG (SEQ ID NO: 10)
[0026] The bar primers were used to PCR-amplify part of the T-DNA portion of the expression construct containing a nucleic acid molecule of the invention, i.e., from genomic DNA of Nicotiana transformants.
[0027] The PCR reaction mixture contained 100 ng genomic DNA of transformed plant, prepared using the cetyltrimethyl-ammonium bromide (CTAB) extraction method (Aldrich and Cullis, Plant MoI. Biol. Report., 11 :128-141 (1993)), 0.2 μM of each primer for the Bar gene, 0.2 μM of each primer for the endogenous CHS control gene, 100 μM of each deoxyribonucleotide triphosphate, IxPCR buffer and 2.5 Units of AmpliTaq DNA polymerase (Applied Biosystems) in a total volume of 50 μL. The cycling parameters were as follows: 94°C. for 1 minute, 57°C. for 1 minute and 72°C for 1 minute, for 40 cycles, with 5 minutes at 72°C. extension. The PCR products were electrophoresed on a 1 % agarose gel.
EXAMPLE 5
[0001] Several independent heterozygous primary transformants from Nicotiana tahacum and Nicotiana benthamiana were self-pollinated to yield the Tl generation. One of these primary transformants (event 50) and its Tl progeny are described here, but other transgenic events had similar phenotypes. Thirty Tl plants from transgenic event 50 were allowed to grow in the greenhouse under conditions sufficient to identify those Tl plants which exhibited altered size and/or architecture of the aerial parts, or altered size and/or architecture of the non-aerial parts, or altered xylem structure and/or xylem chemical composition, or a combination of these effects, according to the descriptions provided herein. Seeds from each plant in this segregating progeny were collected and plated onto MS-agar plates containing 4.5 mg/L Finale to allow for rapid genotyping of the Tl plants.
[0002] AA and A0 Tl plants exhibited normal visual phenotypes when compared to 00 Tl plants from the same progeny.
[0003] Hand-sectioned stem cuts taken from the midpoint of the stem from representative plants possessing each of the three possible Tl genotypes (AA, A0 and 00) were stained with Astra blue/saffranin and observed under a Leica visible light transmission microscope (FIG. 4). AA and A0 plants exhibited a marked increase in the number of radial cell files in the secondary xylem when compared with 00 plants from the same segregating progeny. This increase is mainly due to regions of the cambial zone characterized by agglomerates of cambial cells, probably resulting from increased differentiation of cambial fusiform initials into xylary fibers. This hypothesis is consistent with the notion that class III HD-zip transcription factors regulate xylogenesis in plants (Prigge et al, Plant Cell, 17: 61-76 (2005)).
[0028] The foregoing disclosure and examples describe various features of the invention, which essentially involve the isolation and cloning of nucleic acid molecules encoding transcription factors and are useful in the production of genetically engineered plants. Recombinant plants which have been transformed or transfected with such isolated nucleic acid molecules exhibit improvement in xylem structure, namely an increase in the number of xylem cells, resulting in radially wider secondary xylem in the stem and in the root. Recombinant plants which have been transformed or transfected with such isolated nucleic acid molecules may also exhibit quantitative alteration in lignin or cellulose content and/or lignin composition.
[0029] These isolated nucleic acid molecules encode transcription factors which are members of the "homeodomain-containing", or "HD", family of transcription factors. Members of this family share a conserved DNA-binding domain of 30-60 amino acids, which was first identified in Drosophila homeotic and segmentation proteins, and which binds to DNA through a "helix turn helix" structure.
[0030] These HD transcription factors are divided into three groups, of which the homeodomain-leucine zipper, abbreviated as "HD-zip", is relevant here. The members of this family share a common structural organization, consisting of three main regions. These include conserved b-ZIP and START domains, as well as the HD domain referred to supra (Figure 1). Within this family, proteins are further divided into three classes, of which class III contains the proteins relevant to this patent. Proteins in the HD-zip family have a variety of developmental functions in plants and animals (Johanesson, H., Functional analysis of homeodomain-leucine zipper transcription factors in Arabidopsis thaliana, thesis dissertation, Uppsala University, Sweden), but class III HD-zip proteins seem to be plant-specific factors. What distinguishes the nucleic acid molecules and proteins of the invention is their preferred expression pattern in secondary xylem and cambium tissues of plants. [0031] The isolated nucleic acid molecules of the invention are represented by, but are not limited to, those defined as comprising the nucleotide sequence of SEQ. ID. NO: 1 or 2, as well as those which exhibit 65% or more homology therewith, as is discussed infra.
[0032] The isolated nucleic acid molecules of the invention are capable of hybridizing, under stringent conditions, to one or both of SEQ. ID. NOS: 1 and 2. "Stringent conditions" as defined herein refers to conditions at least as stringent as those where hybridization is carried out in 3.5x SSC, Ix Denhardt's solution, 25mM sodium phosphate buffer (pH 7.0), 0.5% SDS, and 2mM EDTA for 18 hours, at 65°C, followed by four washes at 650C for 20 minutes per wash, in 2x SSC, 0.1% SDS, and a final wash for up to 20 minutes, in 0.5x SSC, 0.1% SDS, or lower concentrations of SSC, e.g., 0.3x SSC, 0.1% SDS or O.lx SSC, 0.1% SDS, for even greater stringency. These conditions will serve as "stringent conditions" throughout this disclosure. Also a part of the invention are those nucleic acid molecules which encode the same protein as the nucleic acid molecules described supra, but differ in nucleotide sequence as a result of degeneracy of the genetic code, as well as those nucleic acid molecules which encode proteins that have at least about 60%, preferably at least about 70%, more preferably at least about 80% and most preferably at least 90% of the activity of SEQ. ID. NOS: 3 and 4.
[0033] The nucleic acid molecules of the invention include, e.g., allelic variants. These are nucleic acid molecules which vary in nucleotide sequence from the reference sequences supra, and lead to changes in amino acid translation, but are subject to no more than about 5% variation in the nucleotide sequence.
[0034] Also included are analogs of the sequences, where the analog has the same function as the sequence, but evolved in a different organism. Orthologs and paralogs are included herein, as these terms are known to the art.
[0035] In one preferred embodiment of the invention, the nucleic acid molecules of the invention contain regions which encode a conserved START domain. With respect to the amino acid sequence listings herein, SEQ. ID. NOS: 3 and 4 present START domains at amino acids 165-375.
[0036] In addition to this, the invention encompasses those nucleic acid molecules which encode proteins that include amino acid sequences that are at least 80%, more preferably 85%, even more preferably at least 90% and most preferably at least 95% identical to the START domain described supra, and which have at least 60% of the biological activity of the proteins encoded by SEQ. ID. NO: 1 or 2. "Biological activity" refers to the properties described in the examples, supra.
[0037] The isolated nucleic acid molecules of the invention may be incorporated into expression vectors, such that they are in operable linkage with a promoter. Preferably, the promoter is one known to operate in plant cells, and more preferably to be operable in cells of specific plant organs or tissues, such as roots, shoots, leaves, xylem, etc. The nucleic acid molecules of the invention may be placed in operable linkage with constitutive or inducible promoters. Alternatively, the nucleic acid molecules of the invention may be placed in operable linkage with promoters which direct the expression of the downstream gene preferably or specifically to an organ or tissue of the plant, such as xylem and cambium.
[0038] The expression vectors of the invention may also contain termination sequences, which are positioned downstream of the nucleic acid molecules of the invention, such that transcription of mRNA is terminated, and polyA sequences added. Exemplary of such terminators are the cauliflower mosaic virus (CaMV) 35S terminator and the nopaline synthase gene (Tnos) terminator.
[0039] The expression vectors of the invention may include a developmentally regulated promoter, an organelle specific promoter, a seed specific promoter, a plastid specific promoter, and so forth. Coding sequences for targeting, transit, or secretion protein encoding molecules may also be included. Enhancers, transcription terminators, start codons, splicing signal sequences, and so forth, may also be included. For example, if a transcription initiation region is included, it may be, e.g., any of the various opine initiation regions, such as octopine, mannopine, nopaline and the like that are found in the Ti plasmids of Agrobacteriiim tumefaciens. Alternatively, plant viral promoters can also be used, such as the cauliflower mosaic virus 35S promoter, to control gene expression in a plant. In addition, plant promoters such as leaf-specific promoters, root-specific promoters, seed-specific promoters, etc. can also be used. The most preferred promoters, as explained supra, are tissue-preferred promoters which are active in, e.g., the cambium and/or xylem, particularly xylem fiber cells.
[0040] Included within the meaning of promoter is a sequence sufficient to direct transcription, such as promoter elements which are sufficient to render promoter-dependent gene expression controllable for cell-type specific, tissue-specific, environmentally- or developmentally-regulated, or expression that is inducible by external signals or agents. Such elements may be located in the 5' and/or 3' regions of the construct. Both constitutive and inducible promoters are included (see e.g., Bitter et al., Methods in Enzymol., 153:516-544 (1987), incorporated by reference).
[0041] The expression of genes employed in the present invention may be driven by more than one promoter in different circumstances. Although the endogenous promoter of a structural gene of interest, for example that of a gene of the present invention, may be utilized for transcriptional regulation of the gene, the promoter may also be a foreign regulatory sequence. For plant expression vectors, suitable viral promoters include the 35S RNA and 19S RNA promoters of CaMV (Brisson et al., Nature, 310:51-61 (1984); Odell et al., Nature, 313:810 (1985)); the enhanced CaMV 35S promoter; the Figwort Mosaic Virus (FMV) promoter (Gowda et al., J. Cell Biochem., 13D:301 (1989); Richins et al., Nucleic Acids Res., 15(20): 8451-66 (1987)) and the coat protein promoter of TMV (Takamatsu et al., EMBO J., 6:307 (1987)), leading to the over-expression of the nucleic acid molecules of the invention in most tissues, in turn leading to changes in xylem structure and/or xylem composition and/or plant size and/or plant architecture.
[0042] Tissue specific promoters may also be utilized in the present invention. As used herein, the term "tissue-specific promoter" means a DNA sequence that serves as a promoter, i.e., regulates expression of a selected DNA sequence operably linked to the promoter, effecting expression of said selected DNA sequence in specific cells, e.g., in the root or in the shoot of a plant. The term also covers the so-called "leaky" promoters, which regulate expression of a selected DNA primarily in one tissue, but may cause minor expression in other tissues as well. Such promoters may also include additional DNA sequences that are necessary for expression, such as introns and enhancer sequences. These additional sequences may be either endogenous to the organism from which the promoter is derived, endogenous to the plant which is being transformed, or may be exogenous to both. Examples of tissue-specific promoters active in floral meristems are the promoters of the Apetala3 and Apetalal genes which are described in Jack et al., Cell, 76:703 (1994) and Hempel et al., Development, 124:3845 (1997).
In addition, vascular system-specific, xylem-specific or xylem preferred promoters may be useful to promote expression of the nucleic acid molecules of the invention specifically in vascular tissues, especially xylem tissue. The use of a constitutive promoter, in general, affects protein levels and functions in all parts of the plant, while use of a tissue-preferred promoter permits targeting of the modified gene expression to specific plant parts, leading to more controllable phenotypes. Thus, in applying the invention, it may be found convenient to use a promoter that will give expression during xylem development, whereby the proteins of the invention would only be overproduced in the organ(s) or tissue(s) or cell type(s) in which its action is required for the uses disclosed herein. Vascular tissue-specific, xylem-specific, vascular tissue-preferred and xylem-preferred promoters that could be used include, but are not limited to, the xylem-preferred tubulin (TUB) gene promoter, the xylem-preferred lipid transfer protein (LTP) gene promoter and the xylem-preferred coumarate-4-hydroxylase (C4H) gene promoter. These and other suitable xylem-preferred promoters are disclosed in international patent application PCT/BR2005/000041, filed March 28, 2005, which is incorporated here by reference.
[0043] The particular promoter selected should be capable of causing sufficient expression to result in the over-expression of the protein of the invention to modify the size of the xylem or to modify the chemical composition of the xylem of a plant or yet a combination of these effects.
[0044] In practice, a constitutive promoter (such as the CaMV promoter discussed supra) or a tissue-specific promoter, preferably a xylem preferred promoter as described supra, is typically ligated to the protein-coding region using standard techniques known in the art. The promoter may be operably linked to the nucleic acid coding region in any manner known to one of skill in the art. The expression unit may be further optimized by employing supplemental elements such as transcription terminators and/or enhancer elements.
[0045] Transcription terminators or termination regions downstream of the structural gene provide for efficient transcription termination. The termination region may be obtained from the same gene as the promoter sequence or may be obtained from a different gene. If the mRNA encoded by the structural gene is to be efficiently processed, DNA sequences which direct polyadenylation sequences, including, but not being limited to, the Agrobacterium octopine synthase signal (Gielen et al., EMBO J., 3:835-846 (1984)) or the nopaline synthase signal (Depicker et al., MoI. And Appl. Genet., 1:561-573 (1982)), are also used.
[0046] When inserted into plants or plant cells, the expression vectors of the invention will typically contain, in addition to the protein coding nucleotide sequence, a plant promoter region, a transcription initiation site and a transcription termination sequence. Unique restriction enzyme sites at the 5' and 3' ends of the expression unit may also be included to allow for easy insertion into a preexisting vector.
[0047] An additional embodiment of the invention is a recombinant expression vector comprising a promoter, said promoter being functional in a plant cell, and a nucleic acid molecule in accordance with the invention, operably linked to said promoter, wherein said nucleic acid molecule comprises a nucleotide sequence of at least 21 contiguous nucleotides from a sequence chosen from SEQ ID. NOS: 1 or 2, in antisense orientation. More preferably, the sequence contains 21 — 300 contiguous nucleotides from a sequence chosen from SEQ ID. NOS: 1 or 2, in antisense orientation. Such constructs are useful for inhibiting and/or decreasing expression of the relevant genes. In another embodiment, the nucleotide sequence comprises a nucleic acid molecule selected from the group consisting of: (a) SEQ. ID. NOS: 1 or 2, or a part thereof, or a complement thereof; (b) a nucleotide sequence that hybridizes to said nucleotide sequence of (a) under a wash stringency equivalent to 0.1X SSC to l.OX SSC, 0.1 % SDS, at 50- 650C, and which encodes a polypeptide having at least 60% of the activity of Populus deltoides polypeptide disclosed herein, (c) a nucleotide sequence encoding a protein having the same amino acid sequence as is encoded by the nucleotide sequence of (a), but which is degenerate in accordance with the degeneracy of the genetic code; and (d) a nucleotide sequence encoding the same amino acid sequence as said nucleotide sequence of (b), but which is degenerate in accordance with the degeneracy of the genetic code.
[0048] Another embodiment of the invention is a recombinant expression vector comprising a promoter functional in a plant cell, a nucleic acid molecule which is a homologue of the nucleotide sequences described supra, and which encodes a polypeptide whose amino acid sequence contains regions that are at least 80% identical to the START domain of SEQ ID. NOS: 3 and 4, as described supra, and which exhibits at least 60% of the biological activity of the polypeptides shown in SEQ ID. NOS: 3 or 4. More preferably, the nucleic acid molecule encodes a polypeptide whose amino acid sequence contains regions that are at least 85%, 90% or even 95% identical to the START sequence supra.
[0049] Expression vectors of the invention may also contain a selection marker by which transformed plant cells can be identified in culture. The marker may be associated with the heterologous nucleic acid molecule, i.e., the gene operably linked to a promoter. As used herein, the term "marker" refers to a gene encoding a trait or a phenotype that permits the selection of, or the screening for, a plant or plant cell containing the marker. Usually, the marker gene will encode antibiotic resistance. This allows for selection of transformed cells from among cells that are not transformed or transfected. Alternatively the marker gene may confer herbicide resistance.
[0050] Examples of suitable selectable markers include adenosine deaminase, dihydrofolate reductase, hygromycin-B-phosphotransferase, thymidne kinase, xanthine-guanine phospho-ribosyltransferase, glyphosate and glufosinate resistance and amino-glycoside 3'-O- phosphotranserase (kanamycin, neomycin and G418 resistance). These markers include resistance to G418, hygromycin, bleomycin, kanamycin, and gentamicin. The construct may also contain the selectable marker gene Bar that confers resistance to herbicidal phosphinothricin analogs like ammonium gluphosinate (Thompson et al, EMBO J. 9:2519-2523 (1987)). Other suitable selection markers are known to those of skill in the art.
[0051] Replication sequences, of bacterial or viral origin, may also be included to allow the vector to be cloned in a bacterial or phage host. Preferably, a broad host range prokaryotic origin of replication is used. A selectable marker for bacteria may be included to allow selection of bacterial cells bearing the desired construct. Suitable prokaryotic selectable markers also include resistance to antibiotics such as kanamycin or tetracycline.
[0052] Other DNA sequences encoding additional functions may also be present in the vector, as is known in the art. For instance, when Agrobacterium is the host, T-DNA sequences may be included to facilitate the subsequent transfer to and incorporation into plant chromosomes.
[0053] A further feature of the invention are proteins and polypeptides encoded by the nucleic acid molecules of the invention, exemplified by, but not being limited to, the polypeptides which have the amino acid sequences of SEQ ID. NOS: 3 and 4. Preferably, the polypeptides of the invention have amino acid sequences which contain regions that are at least 80% identical to the conserved START domain referred to supra. Identity greater than 80% is preferred, while identity greater than 85%, 90% or even 95% with respect to the START domain is preferred. In all cases, the polypeptide has at least 60% of the biological activity of a polypeptide from the group shown in SEQ ID. NOS: 3 or 4.
[0054] As with any protein or polypeptide, antibodies that are specific thereto can be generated, and these antibodies, which may be polyclonal, monoclonal, chimeric, or produced via recombinant means in some way, manner or form, are all covered by the invention as are the means of producing these, including, e.g.,. hybridomas, recombinant cells containing nucleic acid molecules that produce the antibodies, and the antibody-producing nucleic acid molecules themselves.
[0055] The presence of the proteins, polypeptides, and/or nucleic acid molecules in a particular cell can be measured to determine if, e.g., a cell has been successfully transformed or transfected. The ability to carry out such assay is well known and need not be reiterated here.
[0056] The nucleic acid molecules of the invention may be used "neat", or preferably in expression vector constructs, to transform or transfect cells, such as plant cells. Standard molecular biological- techniques, well known to the skilled artisan, may be used.
[0057] Both dicot and monocot cells may be so transformed or transfected. Cells can be so treated before differentiating into plant organs, and can also be treated so as to transform or transfect particular plant organs, such as seeds, fruit, leaves, stems, wood, flowers and so forth. Exemplary of such plants are those which have economic value such as, but not limited to, turf grasses, leafy plants such as tobacco, spinach, and lettuce, maize, wheat, rye, oat, triticale, rice, barley, soybean, peanut, cotton, rapeseed, canola, manioc, pepper, sunflower, marigold, solanaceous plants such as, potato, eggplant, tomato, Vicia species, pea, alfalfa, coffee, cacao, tea, Salix species, oil palm, coconut, perennial grass, forage crops, seed-bearing plant, such as rice, corn, soy and bean, and woody trees, such as poplar, eucalyptus, pine, spruce, fir, etc.
[0058] The methods of the present invention rely on altering plants using molecular techniques. All technical terms used herein are terms commonly used in biochemistry, molecular biology and agriculture, and can be understood by one of ordinary skill in the art to which this invention belongs. Those technical terms can be found in: Molecular Cloning: A Laboratory Manual, 3rd ed., vol. 1-3, ed. Sambrook and Russel, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. (2001); Current Protocols in Molecular Biology, ed. Ausubel et al., Greene Publishing Associates and Wiley-Interscience, New York (1988, with periodic updates); Short Protocols in Molecular Biology: A compendium of Methods from Current Protocols in Molecular Biology, 5th ed., vol. 1-2, ed. Ausubel et al., Jon Wiley & Sons, Inc. (2002); Genome Analysis: A Laboratory Manual, vol. 1-2, ed. Green et al., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. (1997). Methods involving plant biology techniques are described herein and are described in detail in methodology treatises such as Methods in Plant Molecular Biology: A Laboratory Course Manual, ed. Maligna et al., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. 1995).
[0059] Use of these methods in combination with the nucleic acid molecules of the invention results in the transgenic plants and transgenic plant cells discussed supra. Agrobacteήum such as A. turnefaciens or A. rhizogenes can be used, for example, in accordance with Nagel, et al. Microbiol Lett 67: 325 (1990). In brief, the method teaches that Agrobacterium may be transformed with a plant expression vector via, e.g., electroporation, after which the Agrobacterium is introduced to plant cells via, e.g., the well known leaf-disk method. Additional methods for accomplishing this include, but are not limited to, electroporation, particle gun bombardment, calcium phosphate precipitation, and polyethylene glycol fusion, transfer into germinating pollen grains, direct transformation (Lorz, et al., MoI. Genet. 199: 179-182 (1985)), and other methods known to the art. If a selection marker, such as kanamycin resistance, is employed, it makes it easier to determine which cells have been successfully transformed.
[0060] It is to be noted that the Agrobacterium transformation methods discussed supra have been known as being useful for transforming dicots; recently, however, de Ia Pena, et al., Nature 325: 274-276 (1987), Rhodes, et al., Science 240: 204-207 (1988), and Shimamato, et al., Nature 328: 274-276 (1989), all of which are incorporated by reference, have transformed cereal monocots using Agrobacterium. Also see Bechtold, et al., CR. Acad. Sci. Paris 316 (1994), showing the use of vacuum infiltration for Agrobacterium-mediated transformation.
[0061] Of course, it is to be understood that additional methods for transforming and/or transfecting plants with the nucleic acid molecules of the invention are known to the skilled artisan, and need not be reiterated here.

Claims

1. A method for producing a transgenic plant or a transgenic plant part which has (i) altered xylem structure or (ii) altered xylem chemical composition, or (iii) a combination thereof, comprising introducing into a plant cell a nucleic acid molecule which encodes a polypeptide with transcription factor activity, wherein the complement of said nucleic acid molecule hybridizes to at least one of the nucleotide molecules set forth in SEQ. ID. NOS: 1 and 2 under stringent conditions, and cultivating said plant cell to obtain said transgenic plant or plant part.
2. The method of claim 1, wherein said nucleic acid molecule encodes a polypeptide of SEQ. ID. NO: 3 or SEQ. ID. NO: 4, or an active portion thereof.
3. The method of claim 1, wherein said nucleic acid molecule has the nucleotide sequence of SEQ. ID. NO: l or 2.
4. The method of claim 1, wherein said nucleic acid molecule encodes an amino acid sequence comprising a region that is 80% or more identical to the region composed of amino acid residues 165-375 of SEQ. ID. NO: 3 or SEQ. ID. NO: 4.
5. The method of claim 1, wherein said nucleic acid molecule is from a dicot, a monocot, or a gymnosperm.
6. The method of claim 1, comprising introducing said nucleic acid molecule in the form of a construct in which it is operably linked to a promoter.
7. The method of claim 6, wherein said construct further comprises a selection marker.
8. A transgenic plant or plant part produced by the method of claim 1.
9. The transgenic plant of claim 8, wherein said plant is a dicot, monocot, or gymnosperm.
10. The transgenic plant of claim 9, wherein said plant is a woody tree.
11. The transgenic plant of claim 10, wherein said woody tree is Eucalyptus, Popuhis, or Pinus.
12. The transgenic plant part of claim 8, wherein said plant part is a leaf, a stem, a flower, an ovary, a fruit, a seed, a callus, or wood.
13. An isolated nucleic acid molecule, the complementary sequence of which hybridizes, under stringent conditions, to the nucleotide sequence set forth in SEQ. ID. NO: 1 or 2, and which encodes a plant transcription factor.
14. The isolated nucleic acid molecule of claim 13, comprising SEQ. ID. NO: 1 or 2.
15. The isolated nucleic acid molecule of claim 13, which encodes a protein having the amino acid sequence of SEQ. ID. NO: 3 or 4, or a biologically active portion thereof.
16. The isolated nucleic acid molecule of claim 13, which encodes an amino acid sequence that comprises a region that is 80% or more identical to the region composed of amino acid residues 165-375 of SEQ. ID. NO: 3 or 4.
17. Expression vector comprising the isolated nucleic acid molecule of claim 13, operably linked to a promoter.
18. The expression vector of claim 17, further comprising a selection marker.
19. Recombinant cell, transformed or transfected with the expression vector of claim 17.
PCT/BR2006/000050 2005-03-18 2006-03-16 Isolated nucleic acid molecules encoding plant transcription factors in the hd-zip family WO2006096951A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0608683-7A BRPI0608683B1 (en) 2005-03-18 2006-03-16 METHOD FOR PRODUCING TRANSGENIC PLANT OR PART OF TRANSGENIC PLANT SIZED AND / OR ARCHITECTURE OF CHANGED AIRLINES, / OR NON-AERIAL CHEMICAL STRUCTURE OR CHEMICAL COMPOSITION OF THE TRANSLATED CHEMICAL, OR CHINESE CHARACTERISTIC CHARACTERISTIC , EXPRESSION VECTOR, RECOMBINANT CELL

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66302905P 2005-03-18 2005-03-18
US60/663,029 2005-03-18

Publications (2)

Publication Number Publication Date
WO2006096951A2 true WO2006096951A2 (en) 2006-09-21
WO2006096951A3 WO2006096951A3 (en) 2008-01-31

Family

ID=36992076

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2006/000050 WO2006096951A2 (en) 2005-03-18 2006-03-16 Isolated nucleic acid molecules encoding plant transcription factors in the hd-zip family

Country Status (2)

Country Link
BR (1) BRPI0608683B1 (en)
WO (1) WO2006096951A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049373A1 (en) * 2007-10-19 2009-04-23 Australian Centre For Plant Functional Genomics Pty Ltd Modulation of plant cell wall deposition
WO2009150151A1 (en) * 2008-06-10 2009-12-17 Basf Se Deuterated transition metal complex and use thereof in organic light-emitting diodes v

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020160378A1 (en) * 2000-08-24 2002-10-31 Harper Jeffrey F. Stress-regulated genes of plants, transgenic plants containing same, and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020160378A1 (en) * 2000-08-24 2002-10-31 Harper Jeffrey F. Stress-regulated genes of plants, transgenic plants containing same, and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TAMAOKI ET AL. PLANT CELL PHYSIOL. vol. 40, 1999, pages 657 - 667 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049373A1 (en) * 2007-10-19 2009-04-23 Australian Centre For Plant Functional Genomics Pty Ltd Modulation of plant cell wall deposition
WO2009150151A1 (en) * 2008-06-10 2009-12-17 Basf Se Deuterated transition metal complex and use thereof in organic light-emitting diodes v
US8410270B2 (en) 2008-06-10 2013-04-02 Basf Se Transition metal complexes and use thereof in organic light-emitting diodes V
US8592586B2 (en) 2008-06-10 2013-11-26 Basf Se Transition metal complexes and use thereof in organic light-emitting diodes V

Also Published As

Publication number Publication date
BRPI0608683A2 (en) 2010-01-19
BRPI0608683B1 (en) 2018-01-16
WO2006096951A3 (en) 2008-01-31

Similar Documents

Publication Publication Date Title
RU2458132C2 (en) Regulating height of plant gene and its applications
AU728100B2 (en) Shoot meristem specific promoter sequences
JP2004527201A (en) Methods of producing transgenic plants with increased expression of Alfin 1 and increased root growth and specific gene activation of roots
KR20060132442A (en) Novel environmental stress resistance transcription factor and method for enhancing the environmental stress resistance of plants using the same
EP2449111B1 (en) Expression of transcription regulators that provide heat tolerance
CA2727564A1 (en) Methods and means of increasing the water use efficiency of plants
CN110295175B (en) Application of soybean NAC transcription factor family gene Glyma08g41995
JP3357907B2 (en) Method for shortening inflorescence internode by introducing gene of Petunia transcription factor PetSPL2
WO1999000501A1 (en) Materials and methods relating to a plant regulatory protein
WO2006096951A2 (en) Isolated nucleic acid molecules encoding plant transcription factors in the hd-zip family
KR101210308B1 (en) Root hair-specific expression promoter from Oryza sativa EXPB5 gene and uses thereof
WO2008043268A1 (en) Gmrd22-like genes and use thereof to protect against abiotic stress
EP1699926B1 (en) Stress tolerant plants and methods thereof
KR101112673B1 (en) RHS10 gene controlling plant root hair development and a method to control plant root hair development using the gene
KR101112703B1 (en) RHS1 gene controlling root hair development of plants and method for controlling root hair development of plant using the same
KR101322348B1 (en) StEIP gene enhancing resistance to Bacterial wilt and use thereof
WO2006084342A2 (en) Isolated nucleic acid molecules encoding plant transcription factors in the knox family
CN113666993B (en) Alfalfa MsSPL12 protein and related biological materials and application thereof in improving plant stress resistance
KR102173875B1 (en) Composition for enhancing herbicide resistance of plants and method for enhancing herbicide resistance of plants using the same
CN113151268B (en) African agapanthus dehydratin ApY 2 SK 2 Gene promoter sequence and use thereof
KR101486825B1 (en) Promoter of gene specifically expressed in early flower stage in rice and uses thereof
CN113151269B (en) African agapanthus dehydrin protein ApSK 3 Promoter sequence of gene and application thereof
CN112159465B (en) DRN protein and related biological material and application thereof in improving regeneration efficiency of plant somatic cells
KR101341932B1 (en) Gene encoding pepper transcription factor CaWRKY1 having resistance to frost damage and drought disaster, and use thereof
CN114644693B (en) ZmWRKY44 protein, coding gene thereof and application of ZmWRKY44 protein in regulation of plant drought resistance

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

NENP Non-entry into the national phase in:

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06721609

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6721609

Country of ref document: EP

ENP Entry into the national phase in:

Ref document number: PI0608683

Country of ref document: BR

Kind code of ref document: A2